private:neuroproofgmbhrostock-2
|
2221187
|
May 30th, 2019 12:00AM
|
NeuroProof GmbH
|
135
|
6.00
|
Open
|
Biotechnology
|
May 30th, 2019 01:46PM
|
May 30th, 2019 01:46PM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art artificial intelligence based analytics of functional phenotypic activity pattern of test agents on neuronal network activity. The services comprise the growing of neuronal cell cultures prepared from mouse or derived from human iPSC on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell function. NeuroProof has developed a range of in vitro disease models for neurogenerative and psychological disorders.
|
Open
|
CNS Drug Discovery, Combination therapy, Phenotypic sreening with primary neuronal cell cultures, Computational Neuroscience, Artificial intelligence
|
Open
|
Friedrich-Barnewitz-Str. 4
|
Rostock
|
Mecklenburg-Vorpommern
|
DE
|
18119
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Mar 10th, 2018 12:00AM
|
NeuroProof GmbH
|
116
|
7.00
|
Open
|
Biotechnology
|
Mar 9th, 2018 07:28PM
|
Mar 9th, 2018 07:28PM
|
|
Open
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 17th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 16th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 15th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 14th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 13th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 12th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 11th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|
private:neuroproofgmbhrostock-2
|
2221187
|
Feb 10th, 2018 12:00AM
|
NeuroProof GmbH
|
113
|
7.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art mathematical expertise for the phenotypic analysis of test agents on neuronal network activity. The services comprise the growing of primary neuronal cultures on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell functioning.
|
|
|
|
|
|
|
|
|
|
Neuroproof GmbH (Rostock)
|
|
Health Care Equipment & Services
|